(QNTM) Quantum BioPharma - Performance 199.2% in 12m
QNTM performance: live returns, drawdowns, peer ranking & SPY comparison from 1w to 5y, all in one clean chart-driven dashboard.
Performance Rating
-64.86%
#92 in Peer-Group
Rel. Strength
97.65%
#176 in Stock-Universe
Total Return 12m
199.15%
#5 in Peer-Group
Total Return 5y
-87.85%
#107 in Peer-Group
| P/E | Value |
|---|---|
| P/E Trailing | - |
| P/E Forward | - |
| High / Low | USD |
|---|---|
| 52 Week High | 35.00 USD |
| 52 Week Low | 2.91 USD |
| Sentiment | Value |
|---|---|
| VRO Trend Strength +-100 | 99.29 |
| Buy/Sell Signal +-5 | 1.24 |
| Support / Resistance | Levels |
|---|---|
| Support | |
| Resistance |
12m Total Return: QNTM (199.2%) vs XBI (-8.2%)
5y Drawdown (Underwater) Chart
Top Performer in Biotechnology
Overall best picks of Peer Group - Selected by proven GARP Predictive Metrics, sorted by Growth Rating
| Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability | EPS CAGR |
|---|---|---|---|---|---|---|---|---|
| GILD NASDAQ Gilead Sciences |
0.15% | 63.5% | 75.2% | 22.7 | 13.6 | 0.23 | 28.3% | -3.71% |
| UTHR NASDAQ United Therapeutics |
-6.08% | -5.9% | 145% | 12.9 | 12 | 1.43 | 74.6% | 16.1% |
| AMGN NASDAQ Amgen |
5.21% | -3.62% | 44.4% | 26.8 | 13.9 | 0.97 | 0.60% | 41% |
| BIM PA Biomerieux |
1.33% | 35.3% | 6.32% | 33.1 | 25.8 | 1.55 | -38.5% | -25.1% |
| NBIX NASDAQ Neurocrine Biosciences |
2.92% | -5.61% | -0.67% | 42.4 | 24.4 | 0.27 | 18.7% | -34.3% |
| KMDA NASDAQ Kamada |
4.8% | 50.8% | -11.3% | 25.5 | 22.8 | 0.91 | 48.1% | 3.93% |
| PTCT NASDAQ PTC Therapeutics |
6.36% | 50.8% | -5.76% | 7.71 | 6.26 | 0.81 | - | 68% |
| ERF PA Eurofins Scientific SE |
4.53% | 14.3% | 9.9% | 28.9 | 15.1 | 0.63 | -62.1% | -19.3% |
Performance Comparison: QNTM vs XBI vs S&P 500
XBI (SPDR S&P Biotech ETF) is the Sector Benchmark for QNTM
| Total Return (including Dividends) | QNTM | XBI | S&P 500 |
|---|---|---|---|
| 1 Month | 207.29% | 1.20% | 0.24% |
| 3 Months | 418.52% | -4.86% | 5.41% |
| 12 Months | 199.15% | -8.22% | 10.03% |
| 5 Years | -87.85% | -26.18% | 104.87% |
| Trend Score (consistency of price movement) | QNTM | XBI | S&P 500 |
|---|---|---|---|
| 1 Month | 92.7% | 70.6% | 78.8% |
| 3 Months | 87.5% | 23.6% | 79.5% |
| 12 Months | 25.5% | -80.8% | 43% |
| 5 Years | -84.8% | -53.2% | 84% |
| Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XBI | vs. S&P 500 |
|---|---|---|---|
| 1 Month | #1 | 203.63% | 206.55% |
| 3 Month | #2 | 444.99% | 391.92% |
| 12 Month | #5 | 225.93% | 171.89% |
| 5 Years | #105 | -83.53% | -94.07% |
FAQs
Does Quantum BioPharma (QNTM) outperform the market?
Yes,
over the last 12 months QNTM made 199.15%, while its related Sector, the SPDR S&P Biotech (XBI) made -8.22%.
Over the last 3 months QNTM made 418.52%, while XBI made -4.86%.
Performance Comparison QNTM vs Indeces and Sectors
Above 0 means better perfomance compared to Symbol in this Timeframe
QNTM vs. Indices
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| US S&P 500 | SPY | 78.2% | 207.1% | 1065.8% | 189% |
| US NASDAQ 100 | QQQ | 77.8% | 206% | 1064.8% | 189% |
| German DAX 40 | DAX | 78.5% | 210.2% | 1049.8% | 172% |
| Shanghai Shenzhen CSI 300 | CSI 300 | 77.9% | 208.4% | 1066.8% | 186% |
| Hongkong Hang Seng | HSI | 79.5% | 205.2% | 1049.5% | 173% |
| India NIFTY 50 | INDA | 78% | 207.6% | 1065.8% | 200% |
| Brasil Bovespa | EWZ | 77.6% | 207.2% | 1044.6% | 190% |
QNTM vs. Sectors
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Communication Services | XLC | 77.5% | 206.1% | 1061.1% | 176% |
| Consumer Discretionary | XLY | 78.3% | 209.8% | 1074.2% | 182% |
| Consumer Staples | XLP | 77.7% | 209.2% | 1064% | 192% |
| Energy | XLE | 76.8% | 200.8% | 1059.2% | 197% |
| Financial | XLF | 77% | 209.2% | 1062% | 176% |
| Health Care | XLV | 80.4% | 208.9% | 1069.8% | 207% |
| Industrial | XLI | 78% | 208.3% | 1059.4% | 182% |
| Materials | XLB | 78.9% | 208.1% | 1064.7% | 201% |
| Real Estate | XLRE | 77.9% | 207.4% | 1062.4% | 186% |
| Technology | XLK | 77.2% | 204.4% | 1064.4% | 193% |
| Utilities | XLU | 78.6% | 209.7% | 1059.4% | 180% |
| Aerospace & Defense | XAR | 77.4% | 202% | 1046.7% | 157% |
| Biotech | XBI | 79.2% | 206.1% | 1076.4% | 207% |
| Homebuilder | XHB | 77.1% | 211.2% | 1076.8% | 207% |
| Retail | XRT | 75.6% | 206.7% | 1070.9% | 196% |
QNTM vs. Commodities
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Oil | USO | 74.1% | 186% | 1,053% | 194% |
| Natural Gas | UNG | 69.8% | 203.4% | 1055.4% | 206% |
| Gold | GLD | 79.7% | 205.1% | 1038.6% | 157% |
| Silver | SLV | 78.5% | 198.7% | 1045.1% | 182% |
| Copper | CPER | 76% | 203.7% | 1048.4% | 191% |
QNTM vs. Bonds
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| iShares 20+ Years Bond | TLT | 77.6% | 205.7% | 1067% | 203% |
| iShares High Yield Corp. Bond | HYG | 77.2% | 206.2% | 1062.7% | 190% |